These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Experimental studies on specific immunotherapy in nasopharyngeal carcinoma (NPC). Arnold W, Vosteen KH. Arch Otorhinolaryngol; 1980; 229(1):5-11. PubMed ID: 7008757 [Abstract] [Full Text] [Related]
23. EB viral genomes in epithelial nasopharyngeal carcinoma cells. Wolf H, zur Hausen H, Becker V. Nat New Biol; 1973 Aug 22; 244(138):245-7. PubMed ID: 4353684 [No Abstract] [Full Text] [Related]
24. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1. Li X, Liu X, Li CY, Ding Y, Chau D, Li G, Kung HF, Lin MC, Peng Y. Int J Oncol; 2006 Sep 22; 29(3):595-603. PubMed ID: 16865275 [Abstract] [Full Text] [Related]
26. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS. Oncogene; 1992 Nov 22; 7(11):2131-40. PubMed ID: 1331932 [Abstract] [Full Text] [Related]
28. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter. Zhang Y, Wang H, Liu Y, Wang C, Wang J, Long C, Guo W, Sun X. Biomed Pharmacother; 2018 Jun 22; 102():1003-1014. PubMed ID: 29710517 [Abstract] [Full Text] [Related]